[ATX] YoY Quarter Result on 30-Sep-2023 [#Q2]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
29-Sep-2023
Financial Year
2024
Quarter
30-Sep-2023 [#Q2]
Profit Trend
QoQ- 66.11%
YoY- 61.23%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 2,448 1,769 763 860 0 51 657 24.49%
PBT -3,578 -4,640 -2,085 -1,371 -885 -718 -2,495 6.18%
Tax -2,448 -1,728 -763 -860 -0 0 0 -
NP -1,129 -2,912 -1,323 -511 -885 -718 -2,495 -12.37%
Tax Rate - - - - - - - -
Total Cost 3,578 4,681 2,085 1,371 885 769 3,153 2.12%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -46.12 -164.57 -173.45 -59.45 0.00 -1,410.33 -379.58 -29.61%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.11 -32.93%
EPS Diluted -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.11 -32.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.